ACC 2010 schedule: Difference between revisions
Jump to navigation
Jump to search
| Line 104: | Line 104: | ||
===4:30 PM=== | ===4:30 PM=== | ||
===5:00 PM=== | |||
*'''Interviewee:''' Henry Ginsberg | |||
*'''Trial:''' Effects of Combination Lipid Therapy on Cardiovascular Events in Type 2 Diabetes Mellitus: The ACCORD Lipid Study | |||
Revision as of 17:28, 9 February 2010
Here is the page we will use to coordinate interviews at ACC 2010
Filming location: Atlanta Marriott Downtown 160 Spring Street Atlanta, GA 30303
Filming will occur from Saturday to Tuesday (March 13 - March 16). Dr. Gibson is available to interview during all times listed in black. For all times listed in green, Dr. Gibson is unavailable to conduct the interview. You may, however, go ahead and speak about your topic/present your slides.
Click on Date for Detailed Schedule
Saturday, March 13, 2010
8:30 AM
9:00 AM
- Interviewee:
- Trial:
9:30 AM
10:00 AM
- Interviewee:
- Trial:
10:30 AM
- Interviewee:
- Trial:
11:00 AM
11:30 AM
12:00 PM
12:30 PM
1:00 PM
1:30 PM
2:00 PM
2:30 PM
3:00 PM
3:30 PM
4:00 PM
4:30 PM
Sunday March 14, 2010
8:30 AM
9:00 AM
9:30 AM
10:00 AM
10:30 AM
11:00 AM
11:30 AM
12:00 PM
12:30 PM
1:00 PM
1:30 PM
- Interviewee:
- Trial:
2:00 PM
- Interviewee: Francois Schiele
- Trial: Effects of Clinical Characteristics and Treatments on Gender Difference in Outcomes after Acute Myocardial Infarction: A Propensity Score-Matched Analysis
2:30 PM
3:00 PM
3:30 PM
4:00 PM
4:30 PM
5:00 PM
- Interviewee: Henry Ginsberg
- Trial: Effects of Combination Lipid Therapy on Cardiovascular Events in Type 2 Diabetes Mellitus: The ACCORD Lipid Study
Monday March 15, 2010
8:30 AM
9:00 AM
- Interviewee: Robert A. Byrne
- Trial: Randomized Trial of a Polymer-Free Dual Drug-Eluting Stent versus Polymer-Based Cypher and Endeavor Drug-Eluting Stents - Two-year Clinical and Angiographic Outcomes
9:30 AM
- Interviewee: Steven Goldman
- Trial: A Randomized Trial Radial Artery Grafts versus Saphenous Vein Grafts in Coronary Artery Bypass Surgery: VA Cooperative Study
10:00 AM
- Interviewee: Ted Feldman
- Trial: Primary Safety and Efficacy Endpoints of the EVEREST II Randomized Clinical Trial
10:30 AM
- Interviewee: Michael D. Ezekowitz
- Trial: A Randomized Clinical Trial of Three Doses of a Long-Acting Oral Direct Factor Xa Inhibitor Betrixaban in Patients With Atrial Fibrillation
11:00 AM
- Interviewee:
- Trial:
11:30 AM
- Interviewee:
- Trial:
12:00 PM
12:30 PM
1:00 PM
1:30 PM
2:15 PM
- Interviewee: Isabelle C. Van Gelder
- Trial: Rate Control Efficacy in Permanent Atrial Fibrillation: a Comparison Between Lenient Versus Strict Rate Control in Patients With and Without Heart Failure. The RACE II Study
2:30 PM
3:00 PM
3:30 PM
4:00 PM
4:30 PM
Tuesday March 16, 2010
8:30 AM
9:00 AM
9:30 AM
- Interviewee: Robert E. Michler
- Trial: Influence of Reduction of Left Ventricular Volume on Outcome After Coronary Artery Bypass Grafting With or Without Surgical Ventricular Reconstruction